These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7866104)

  • 1. Serum screening for Down's syndrome. Keeping the concept of risk simple.
    Barrow M; Smith JF; Stewart C
    BMJ; 1994 Nov; 309(6965):1373. PubMed ID: 7866104
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum screening for Down's syndrome. Counselling should emphasise possible outcomes of screening.
    Allaby M
    BMJ; 1994 Nov; 309(6965):1373. PubMed ID: 7866103
    [No Abstract]   [Full Text] [Related]  

  • 3. Antenatal screening for neural tube defects and Down's syndrome--the importance of pretest counselling.
    Seman E
    Med J Aust; 1994 May; 160(10):658-60. PubMed ID: 8177121
    [No Abstract]   [Full Text] [Related]  

  • 4. Estimating risk of Down's syndrome.
    BMJ; 1991 Jun; 302(6791):1536-7. PubMed ID: 1830232
    [No Abstract]   [Full Text] [Related]  

  • 5. Maternal serum screening for neural tube defects and Down's syndrome.
    Robertson EF
    Med J Aust; 1991 Sep; 155(5):349. PubMed ID: 1832734
    [No Abstract]   [Full Text] [Related]  

  • 6. Prenatal screening for Down's syndrome.
    BMJ; 1991 Sep; 303(6804):715-6. PubMed ID: 1833015
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prenatal screening for Down's syndrome].
    Qin Q; Christiansen M; Norgaard-Pedersen B
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):694-7. PubMed ID: 9639772
    [No Abstract]   [Full Text] [Related]  

  • 8. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening for Down's syndrome in the second trimester].
    Goldman A; Hod M; Friedman S; Ovadia J
    Harefuah; 1991 Aug; 121(3-4):113-6. PubMed ID: 1836449
    [No Abstract]   [Full Text] [Related]  

  • 11. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
    Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
    Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [First trimester ultrasound screening for nuchal translucency as marker of Down's syndrome].
    Herman A; Maymon R; Dreazen E; Bukovsky I; Weinraub Z
    Harefuah; 1997 Jan; 132(2):94-100. PubMed ID: 9119309
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for Down's syndrome. Conclusions do not reflect reality.
    Reynolds T
    BMJ; 2002 Jan; 324(7329):111. PubMed ID: 11808522
    [No Abstract]   [Full Text] [Related]  

  • 14. Integrated screening for Down's syndrome.
    Chen FM
    J Fam Pract; 1999 Nov; 48(11):846-7. PubMed ID: 10907617
    [No Abstract]   [Full Text] [Related]  

  • 15. 46,XY,i(21q) identified by maternal serum screening.
    Meyers CM; Ghori S; Roberson AE; Blitzer MG; Cohen MM
    Md Med J; 1997 Feb; 46(2):88-9. PubMed ID: 9029908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the risk of Down's syndrome in antenatal screening and the gestation at which this risk applies.
    Morris JK; Wald NJ
    J Med Screen; 2007; 14(1):5-7. PubMed ID: 17362564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal screening for Down syndrome.
    Ogle RF; Chitty LS
    Hosp Med; 1998 Aug; 59(8):632-6. PubMed ID: 9829057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rapid prenatal diagnosis of Down's syndrome in the first trimester of pregnancy by fluorescence in situ hybridization].
    Xiang Y; Sun N; Wang F
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):646-8. PubMed ID: 9639761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for Down's syndrome. Modelling does not predict reality accurately.
    Howe D
    BMJ; 2002 Jan; 324(7329):111-2. PubMed ID: 11808523
    [No Abstract]   [Full Text] [Related]  

  • 20. [Arguments for offering triple test serum screening for Down's syndrome to all pregnant women].
    van der Maas PJ; Dondorp WJ
    Ned Tijdschr Geneeskd; 2002 Mar; 146(11):501-3. PubMed ID: 11925798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.